Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker. - Wikidata - awgldk - TriplyDB

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.

http://www.wikidata.org/entity/Q34588329

about

Adherens junction protein nectin-4 is the epithelial receptor for measles virus New viruses for cancer therapy: meeting clinical needs From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein Measles to the Rescue: A Review of Oncolytic Measles Virus Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbilliviruses Viral oncolysis - can insights from measles be transferred to canine distemper virus?Antibody neutralization of retargeted measles viruses.Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer Pathological consequences of systemic measles virus infection.The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis.Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer.Wild-Type Measles Virus is Intrinsically Dual-Tropic.Oncolysis by paramyxoviruses: preclinical and clinical studies.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4.Placental transcriptome co-expression analysis reveals conserved regulatory programs across gestation.A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.Development of new therapy for canine mammary cancer with recombinant measles virus.A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development.Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.A role for PVRL4-driven cell-cell interactions in tumorigenesis.Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells.Cell-to-Cell Contact and Nectin-4 Govern Spread of Measles Virus from Primary Human Myeloid Cells to Primary Human Airway Epithelial Cells Oncolytic measles virus strains as novel anticancer agents.Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.RETRACTED: Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis.The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.Using antibodies to target cancer therapeutics.Antitumor Virotherapy by Attenuated Measles Virus (MV).Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity.NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade.Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.Down-regulation of nectin-4 inhibits apoptosis in systemic lupus erythematous (SLE) through targeting Bcl-2/Bax pathway.

P2860

Q24295305-AA7EEC8F-BDE0-4096-94E1-F6AB097DE3AC Q24567699-72E744CA-3DF5-4ED0-BA5C-2E253731D87E Q26822694-B0BF51F9-0BF7-4122-8949-3E405975B82B Q28069519-1AF27BBE-B28D-4E55-856F-F57F08831C62 Q28072097-F9FCC1DC-AE44-42AE-AB4B-F172E7806497 Q30557338-2B4B1FAE-C937-4B55-87D9-D3BCFBCD6428 Q33820699-0B1BE070-8E30-4090-85D4-7C55891E9049 Q33820717-5BAE60ED-C266-4137-BED2-EEED4C2513C4 Q34010344-3D2089C3-55EB-4E44-9EA2-9449B8F5CBDF Q34013640-587BFFC0-43EB-4DF7-B601-D1F815A7132B Q34284302-94CAF584-1961-4948-BF2B-83478668F741 Q34442341-A2C20890-B7D1-4DEC-8537-AF26BAADAFAA Q35080037-22646357-B227-488E-89B8-782FDB81CCA9 Q35226511-8DFF0750-9BF4-42A6-A57E-9143BE51891E Q35294099-9507D806-76DD-4E2E-B7A4-46381797265A Q35747417-04B268E4-A981-4A0E-B9C4-87A80E912083 Q35861933-7CCC337B-8678-4D64-89F7-8FD33D7FA3B6 Q35861936-A832F525-F25D-43EA-BD2C-8C19BF71B3F9 Q36101780-BD9B9837-CEFD-4DF8-B7F0-295CF396723F Q36238773-6F583FB5-0F5F-4CAC-B7EA-004F0DE7CC69 Q36413058-76EE938A-C041-4C4F-825A-9237D72D30CF Q36664263-6F7A861E-252E-477F-BC38-DE98038BCCA2 Q36674694-EC657F33-718E-41E5-8094-00F80804490C Q36750564-FA27B80D-3BCD-4B5D-B26D-007A680087F9 Q36810205-2A51026E-C503-4877-82F1-2D0BE6853CA3 Q36810255-D1AEE39B-796C-4050-B6C3-F003D870A7DE Q37093457-49294E57-2ADE-4F9F-8CCE-437CA4EB7B63 Q37261017-2844A152-0B5B-41B8-971C-9537065EC294 Q37462626-3150B829-A330-420C-8B98-577F8F9E34DD Q37479727-A22748FD-4A48-4A91-A1B7-CE2FADA660AA Q37706054-28605BDA-74AF-4A5F-ACB3-D0EB1892BF16 Q38014920-D9507CB3-D94A-424D-8B34-BCF1B9409C76 Q38212137-83B9A200-2D65-4C47-9A83-1E5C19E2FDAF Q38714305-EBE80410-9550-45F8-AD3A-8D873951993F Q38715123-D2B0F84B-3900-4598-9489-07957BB8E9A0 Q38754467-160D5639-7142-41F8-B0AB-1DB9C4919F7B Q38845078-E4C3B174-6E81-497A-A3DF-AB8C9F680EF3 Q38858851-29DE418F-C234-49C4-A54D-8754B061E1EE Q39327842-237D1721-DAB5-43EB-9054-F5C40394A7D4 Q40263037-D5699F18-F432-4F29-88BB-DD3B6E9DC0BD

P2860

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.

http://www.wikidata.org/entity/Q34588329

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@ast

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@en

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@nl

type

label

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@ast

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@en

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@nl

prefLabel

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@ast

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@en

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@nl

P1433

Q34588329-6B472015-84CE-4ED8-8177-548A3AA4E5A6

P1476

Q34588329-802E0BAF-BE96-48CE-B319-8230709E662B

P2093

Q34588329-488D27AD-34CD-4D67-BD60-3AE42E457A0F

Q34588329-8034F9F0-218A-4DD0-9CF3-3DC5E86A7CA3

Q34588329-89E677CE-61F6-45A0-B3B4-1D8D7B27C970

Q34588329-98840F01-DBC6-4014-8149-197D24E97377

Q34588329-9C3A4904-B3C3-4B0B-B4B9-5336D951DA9E

Q34588329-BC95C057-83A3-40D9-88F8-8D356FD8B6B3

Q34588329-CC6218CD-4D71-4849-BEC7-0D7F4E15898B

Q34588329-D4F382EE-A7D8-47DA-8DB7-ACD100FF6559

Q34588329-DACF8AAA-8752-43F3-ACE1-DF005F24CC54

Q34588329-E6DF2FEA-AA45-48E7-B2C1-31E9DE2CF7D9

P2860

Q34588329-1284D82E-94EE-4530-9E92-A9B6BC321100

Q34588329-200EA661-B033-4472-9D5C-FE62A27F4A8D

Q34588329-21BF9CC9-9F4B-420B-8AED-7F66401B5F7F

Q34588329-2252F0D1-6291-4E9B-B1F8-B60D611B2085

Q34588329-29453465-7730-4E1A-975A-B6ADB7465BBA

Q34588329-595CD886-1081-42FB-815C-5C3C771049BE

Q34588329-5CDEF316-B1EE-4200-AF94-B38D98C9A090

Q34588329-6EDC4D86-23B4-4208-B1EF-D27B388AD52F

Q34588329-6F0A82E0-0FCA-472E-863F-E1ECF7753A0B

Q34588329-729AA96C-F59D-4CE4-9F62-25CD8A08890B

P304

Q34588329-EC1417E8-849E-4D5E-8E11-2D78F226D7A8

P31

Q34588329-0711C590-C2B4-43C6-837E-A7047D457F46

P356

Q34588329-961FCDF0-C274-4611-BF8C-252E2AC34A27

P407

Q34588329-0F36FB36-2B30-40AC-B623-A7E9B91E6E55

P433

Q34588329-F4CD3AC4-661B-4DC2-86A2-BD0EC50DC609

P478

Q34588329-F76D4600-300F-46C8-89F4-5DE9615459E9

P577

Q34588329-E3DEA65F-E154-4475-9CA8-E19576D5B187

P698

Q34588329-43422906-7F8E-47D3-A257-E9B35B92A4E4

P921

Q34588329-0CB375B3-CD7A-4713-B8E1-7C29E1D1C175

Q34588329-58649172-1E38-4260-94AA-D4CDC4915E18

Q34588329-8CA5D953-D22E-45F8-A4B6-9BCA0F307B6F

P932

Q34588329-FBB25816-AB2D-48D9-BE68-8C8AEF55421C

P356

AJCPGXK0FR4MHIHB

P1433

American Journal of Clinical Pathology

P1476

Nectin 4 overexpression in ova ...... ial role as a serum biomarker.

@en

P2093

Abderrezak Ghidouche

http://www.w3.org/2001/XMLSchema#string

Amy P N Skubitz

http://www.w3.org/2001/XMLSchema#string

C Blake Gilks

http://www.w3.org/2001/XMLSchema#string

Katherine M Harrington

http://www.w3.org/2001/XMLSchema#string

Marc Lopez

http://www.w3.org/2001/XMLSchema#string

Melissa A Geller

http://www.w3.org/2001/XMLSchema#string

Melissa S Derycke

http://www.w3.org/2001/XMLSchema#string

Peter A Argenta

http://www.w3.org/2001/XMLSchema#string

Robin L Bliss

http://www.w3.org/2001/XMLSchema#string

Stefan E Pambuccian

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis

Cancer statistics, 2008

Human nectin3/PRR3: a novel member of the PVR/PRR/nectin family that interacts with afadin

Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin 4 bind to the predicted C-C'-C"-D beta-strands of the nectin1 V domain

Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction

Cancer statistics, 2009

Nectin-4 is a new histological and serological tumor associated marker for breast cancer.

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance.

CA 125: fundamental and clinical aspects.

Early detection of ovarian cancer: promise and reality.

P304

835-845

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1309/AJCPGXK0FR4MHIHB

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20959669

http://www.w3.org/2001/XMLSchema#string

P921

P932

3042138

http://www.w3.org/2001/XMLSchema#string